|
|
Article: GlaxoSmithKline plc - Commencement of Dealings.
- Article from:
- PR Newswire
- Article date:
- December 27, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PHILADELPHIA and RESEARCH TRIANGLE PARK, N.C., Dec. 27 /PRNewswire/ --
GlaxoSmithKline plc (NYSE: GSK; LSE), one of the world's leading research- based pharmaceutical and healthcare companies, confirms that the scheme of arrangement to create GSK will become effective today. Dealings in the shares of GSK will commence today on the London Stock Exchange. Dealings in GSK American Depositary Receipts (ADRs) will also begin today on the New York Stock Exchange.
"GlaxoSmithKline is well placed to respond to the healthcare challenges of the twenty-first century," said Jean-Pierre Garnier, Chief Executive Officer. "It is a market leader in four of the five ...